Abstract
In June 2010, Fosun and Club Med agreed to set up a strategic partnership. Concretely, Fosun would acquire 7.1% stake of Club Med with 20 million euros (220 million RMB), making it the biggest shareholder of Club Med. Club Med finally found a pillar for its ambitious expansion plans in China - Fosun promised to be a long-term investor and to help Club Med to rollout its roadmap in this New World full of opportunities. This international marriage so-far-so-good, will it have a happy ending? Or it will result in a bitter pill for both (not rare in similar cases)? In a wider prospect, will it be the prelude for the epic of Fosun’s internationaliation? Could it become one of the rare successful models of overseas acquisition for the Chinese private company? Or it will turn out to be a pure capital investment, like many others done by new monies from emerging economies? In the following part of this business case, we invite you to join Fosun’s adventure of internationalisation by acquisition and will share with you our personal witness and analysis.